First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) News

Latest headlines that mention TRAX, newest first · each headline opens the original publisher

TRAX quote

Last price: $43.48
Day change: -1.29%
Next earnings: 2026-11-11

Quote & chart Expected move Insider trading IV rank history

TRAX headlines

latest coverage

Seeking Alpha 11d ago

First Tracks Biotherapeutics announces $200M private placement

General T2TRAX

Seeking Alpha News 12d ago

First Tracks Biotherapeutics: Teva Validated The Pathway, ANB033 May Own The Receptor

General T2TEVA TRAX

IBD 14d ago

Why This IPO Stock, An AnaptysBio Spinoff, Just Surged

First Tracks Biotherapeutics posted "impressive" results for its celiac disease treatment Monday, and the IPO stock surged. The post Why This IPO Stock, An AnaptysBio Spinoff, Just Surged appeared first on Investor's Business Daily .

M&A T2ANAB TRAX

Investing.com 15d ago

Why is First Tracks Biotherapeutics stock surging today?

General T3TRAX

Seeking Alpha 2mo ago

First Tracks Biotherapeutics Q2 Non-GAAP EPS of -$0.95

Earnings T2TRAX

Seeking Alpha 5mo ago

First Tracks Biotherapeutics, Inc. reports Q1 results

Earnings T2TRAX

Investing.com 5mo ago

Form S-1 First Tracks Biotherapeutics For: 8 May

IPO T3TRAX

Also mentioned with TRAX

30d

ANAB1
TEVA1

Headlines that tag both tickers

TRAX news alerts

Get an alert by email or push when a new headline mentions TRAX.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.